Flat adenomas in a colon cancer-prone kindred

Journal of the National Cancer Institute

Volumn 80, Issue 4, 1988, Pages 278-282

  Lynch, Henry T ^a   Smyrk, Tom ^a   Lanspa, Stephen J ^a   Marcus, Joseph N ^a   Kriegler, Mary ^a   Lynch, Jane F ^a   Appelman, Henry D ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; ADULT; COLON CANCER; FEMALE; HEREDITY; HISTOLOGY; HUMAN; MALE; PHENOTYPE;

ADENOMA; ADULT; AGED; COLONIC NEOPLASMS; COLONIC POLYPS; FEMALE; HUMAN; MALE; MIDDLE AGE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023914595     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/80.4.278     Document Type: Article

References (21)

1. Perez CA, Knapp RC, DiSaia PJ, et al. Gynecologic tumors, chap 32. In: DeVila VT Jr, ed. Cancer principles and practice of oncology. Philadelphia: Lippincott, 1985:1013-1081.
2. Podratz. KC, O’Brien. PC, Malkasian, GD, et al. The effects of progestational agents in thetreatment of endometrial carcinoma. Obstet Gynecol 1985;66:106-110.
3. Thigpen JT, Buchsbaum HJ, Mangan C, et al. Phase II trial of adriamyrin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Cancer Treat Rep 1979;63:21-27.
4. Thigpen JT, Blessing JA, LaGasse LD, et al. Phase n trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma. Am J Clin Oncol 1984;7:253-256.
5. Seski JC, Edwards CL, Herson J, et al. Cisplatin chemotherapy for disseminated endometrial carcinoma. Obstet Gynecol 1982, 59: 225-228.
6. Edmonson JH, Krook JE, Hilton JF, et al. Randomized phase n studies of cisplatin and a combination of cyclophosphamide- doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma. Gynecol Oncol 1987;28:20-24.
7. Canetta R, Rozencweig M, Carter S. Carboplatin: the clinical spectrum to date. Cancer Treat Rev 1985;12:125-136.
8. Foster BJ, Clagett-Carr K, Leyland-Jones B, et al. Results of NCI-sponsored phase I trials with carboplatin. Cancer Treat Rev 1985;12:43-49.
9. Meckun JP. Frequency of hereditary colorectal carcinoma. Gastroenterology 1987; 93:1021-1025.
10. Muto T, Kamiya J, Sawada T, et al. Small “flat adenoma" of the large bowel with special reference to its clinical pathologic features. Dis Colon Rectum 1985;28:847-851
11. Lynch PM, Lynch HT, eds. Colon cancer genetics. New York: Van Nostrand-Reinhold, 1985.
12. Lynch HT, Rozen P, Schuelke GS, et al. Hereditary colorectal cancer review, colonic polyposis and nonpolyposis colonic cancer (Lynch syndromes I and LI). Surv Dig Dis 1984;2:244-260.
13. Burt RW, Bishop DT, Cannon LA, et al. Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med 1985;312:1540-1544.
14. Love RR. Adenomas are precursor lesions for malignant growth in nonpolyposis hereditary carcinoma of the colon and rectum. Surg Gynecol Obstet 1986;162:8-12.
15. Meckun JP, Sipponen P, Jarvinen HJ. Histopathology of colorectal carcinomas and adenomas in cancer family syndrome. Dis Colon Rectum 1986;29:849-853.
16. Love RR, Morrissey JF. Colonoscopy in asymptomatic individuals with a family history of colorectal cancer. Arch Intern Med 1984;144:2209-2211.
17. Sondergaard JO, Svendsen LB, Wnr IN, et al. Mandibular osteomas in the cancer family syndrome. Br J Cancer 1985;52:941- 943.
18. Lane N, Lev R. Observations on the origin of adenomatous epithelium of the colon: serial section studies of minute polyps in familial polyposis. Cancer 1963;16:751-764
19. O’Leary AD, Sweeney EC. Lymphoglandu- lar complexes of the colon: structure and distribution. Histopathology 1986;10:267-283
20. Oohara T, Ogino A, Tomma H. Microscopic adenoma in nonpolyposis coli: incidence and relation to basal cells and lymphoid follicles. Dis Colon Rectum 1981;24:120-126.
21. Sharp JG, Crouse DA, Purtilo DT. Ontogeny and regulation of the immune system. Arch Pathol Lab Med 1987;111:1106-1113.